Related references
Note: Only part of the references are listed.Impact of Lymphadenectomy on the Oncologic Outcome of Patients With Adrenocortical Carcinoma
Joachim Reibetanz et al.
ANNALS OF SURGERY (2012)
Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas Insights from the largest single-institutional experience
Montserrat Ayala-Ramirez et al.
CANCER (2012)
Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status
Graeme Eisenhofer et al.
EUROPEAN JOURNAL OF CANCER (2012)
Adrenocortical carcinoma: effect of hospital volume on patient outcome
Celestino Pio Lombardi et al.
LANGENBECKS ARCHIVES OF SURGERY (2012)
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
Martin Fassnacht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma
Matthias Kroiss et al.
CLINICAL ENDOCRINOLOGY (2011)
Mitotane has a strong and a durable inducing effect on CYP3A4 activity
Nielka P. van Erp et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Plasma Concentrations of o,p′DDD, o,p′DDA, and o,p′DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study
Ilse G. Hermsen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors
Wiebke Arlt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators
Montserrat Ayala-Ramirez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Adrenocortical carcinoma: a clinician's update
Martin Fassnacht et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Retrospective Evaluation of the Outcome of Open Versus Laparoscopic Adrenalectomy for Stage I and II Adrenocortical Cancer
Francesco Porpiglia et al.
EUROPEAN UROLOGY (2010)
High Diagnostic and Prognostic Value of Steroidogenic Factor-1 Expression in Adrenal Tumors
Silviu Sbiera et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Adjuvant Therapy in Patients With Adrenocortical Carcinoma: A Position of an International Panel
Alfredo Berruti et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Pathogenesis of adrenocortical cancer
Jerome Bertherat et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Limited Prognostic Value of the 2004 International Union Against Cancer Staging Classification for Adrenocortical Carcinomas
Martin Fassnacht et al.
CANCER (2009)
Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma
Sara Gonias et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Gene Expression Profiling Reveals a New Classification of Adrenocortical Tumors and Identifies Molecular Predictors of Malignancy and Survival
Aurelien de Reynies et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Approach to the patient - Preoperative management of the pheochromocytoma patient
Karel Pacak
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas
Laurence Amar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Adjuvant mitotane treatment for adrenocortical carcinoma
Massimo Terzolo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Pheochromocytoma: recommendations for clinical practice from the First International Symposium
Karel Pacak et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma
Henri J. L. M. Timmers et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Management of patients with adrenal cancer: recommendations of an international consensus conference
DE Schteingart et al.
ENDOCRINE-RELATED CANCER (2005)
Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma
L Amar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Adrenocortical carcinomas: Surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group
P Icard et al.
WORLD JOURNAL OF SURGERY (2001)